GAROFALO HEALTH CARE SPA (GHC.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:GHC - IT0005345233 - Common Stock
5.37 EUR
+0.01 (+0.19%)
Overall GHC gets a fundamental rating of 4 out of 10. We evaluated GHC against 27 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of GHC get a neutral evaluation. Nothing too spectacular is happening here. GHC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
GHC had positive earnings in the past year.
In the past year GHC had a positive cash flow from operations.
GHC had positive earnings in each of the past 5 years.
Each year in the past 5 years GHC had a positive operating cash flow.
1.2 Ratios
GHC has a better Return On Assets (3.66%) than 62.96% of its industry peers.
GHC has a Return On Equity of 9.57%. This is comparable to the rest of the industry: GHC outperforms 48.15% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.52%, GHC is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for GHC is below the industry average of 6.91%.
The last Return On Invested Capital (6.52%) for GHC is above the 3 year average (4.41%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROIC | 6.52% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
1.3 Margins
GHC's Profit Margin of 4.62% is fine compared to the rest of the industry. GHC outperforms 70.37% of its industry peers.
GHC's Profit Margin has declined in the last couple of years.
GHC has a Operating Margin of 9.37%. This is in the better half of the industry: GHC outperforms 77.78% of its industry peers.
In the last couple of years the Operating Margin of GHC has declined.
GHC has a Gross Margin of 44.90%. This is in the better half of the industry: GHC outperforms 70.37% of its industry peers.
GHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% |
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
2. Health
2.1 Basic Checks
GHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
GHC has about the same amout of shares outstanding than it did 1 year ago.
GHC has more shares outstanding than it did 5 years ago.
GHC has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.95 indicates that GHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
GHC's Altman-Z score of 1.95 is in line compared to the rest of the industry. GHC outperforms 51.85% of its industry peers.
GHC has a debt to FCF ratio of 70.49. This is a negative value and a sign of low solvency as GHC would need 70.49 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 70.49, GHC is doing worse than 66.67% of the companies in the same industry.
GHC has a Debt/Equity ratio of 0.67. This is a neutral value indicating GHC is somewhat dependend on debt financing.
GHC has a better Debt to Equity ratio (0.67) than 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Altman-Z | 1.95 |
ROIC/WACC1.01
WACC6.48%
2.3 Liquidity
A Current Ratio of 1.16 indicates that GHC should not have too much problems paying its short term obligations.
GHC has a Current ratio (1.16) which is comparable to the rest of the industry.
A Quick Ratio of 1.12 indicates that GHC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.12, GHC is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The earnings per share for GHC have decreased strongly by -12.11% in the last year.
The Earnings Per Share has been growing by 8.81% on average over the past years. This is quite good.
Looking at the last year, GHC shows a quite strong growth in Revenue. The Revenue has grown by 10.44% in the last year.
GHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.92% yearly.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
3.2 Future
The Earnings Per Share is expected to grow by 6.47% on average over the next years.
Based on estimates for the next years, GHC will show a small growth in Revenue. The Revenue will grow by 1.51% on average per year.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
GHC is valuated correctly with a Price/Earnings ratio of 14.92.
Based on the Price/Earnings ratio, GHC is valued a bit cheaper than 74.07% of the companies in the same industry.
GHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.15.
The Price/Forward Earnings ratio is 16.62, which indicates a correct valuation of GHC.
GHC's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of GHC to the average of the S&P500 Index (36.12), we can say GHC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.92 | ||
| Fwd PE | 16.62 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GHC is valued cheaper than 81.48% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GHC is valued a bit more expensive than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 149.13 | ||
| EV/EBITDA | 7.4 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GHC does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of GHC may justify a higher PE ratio.
PEG (NY)4.33
PEG (5Y)1.69
EPS Next 2Y5.05%
EPS Next 3Y6.47%
5. Dividend
5.1 Amount
GHC has a Yearly Dividend Yield of 1.63%.
Compared to an average industry Dividend Yield of 2.09, GHC has a dividend in line with its industry peers.
GHC's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.63% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
BIT:GHC (11/25/2025, 5:22:59 PM)
5.37
+0.01 (+0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.44%
Inst Owner ChangeN/A
Ins Owners62.9%
Ins Owner ChangeN/A
Market Cap484.37M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (25.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.63% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.92 | ||
| Fwd PE | 16.62 | ||
| P/S | 0.7 | ||
| P/FCF | 149.13 | ||
| P/OCF | 17.34 | ||
| P/B | 1.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.4 |
EPS(TTM)0.36
EY6.7%
EPS(NY)0.32
Fwd EY6.02%
FCF(TTM)0.04
FCFY0.67%
OCF(TTM)0.31
OCFY5.77%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.33
PEG (5Y)1.69
Graham Number5.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROCE | 9.13% | ||
| ROIC | 6.52% | ||
| ROICexc | 6.77% | ||
| ROICexgc | 14.86% | ||
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% | ||
| FCFM | 0.47% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Debt/EBITDA | 2.47 | ||
| Cap/Depr | 94.13% | ||
| Cap/Sales | 3.57% | ||
| Interest Coverage | 6.62 | ||
| Cash Conversion | 30.7% | ||
| Profit Quality | 10.18% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.95 |
F-Score5
WACC6.48%
ROIC/WACC1.01
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year67.89%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%
GAROFALO HEALTH CARE SPA / GHC.MI FAQ
Can you provide the ChartMill fundamental rating for GAROFALO HEALTH CARE SPA?
ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.
Can you provide the valuation status for GAROFALO HEALTH CARE SPA?
ChartMill assigns a valuation rating of 4 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for GAROFALO HEALTH CARE SPA?
GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.
What are the PE and PB ratios of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The Price/Earnings (PE) ratio for GAROFALO HEALTH CARE SPA (GHC.MI) is 14.92 and the Price/Book (PB) ratio is 1.45.
How financially healthy is GAROFALO HEALTH CARE SPA?
The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.